Hello
We are preparing a submission to NICE regarding niraparib becoming available for first-line treatment on the NHS.
The name of the NICE consultation is: Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy.
It would be really helpful if any of you who are taking niraparib or who took part in the PRIMA trial (or have experience of taking PARP inhibitors as part of first-line treatment) have comments you'd be willing for us to share within our submission - we wouldn't use your name or any identifying details.
Do get in touch if you have any questions.
Many thanks for your help, as always.
Best wishes
Julia (Ovacome Support Services Officer)